ArticleActa endocrinologica (Bucharest, Romania : 2005)
ASSOCIATION BETWEEN SARCOPENIA AND INSULIN RESISTANCE IN MIDDLE-AGED AND OLDER PEOPLE WITH TYPE 2 DIABETES MELLITUS.
Article in Acta endocrinologica (Bucharest, Romania : 2005). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To probe into the potential connection between sarcopenia and insulin resistance in middle-aged and older cases with type 2 diabetes mellitus (T2DM). Methods: Ninety-six middle-aged and older patients with T2DM were selected. Bioelectrical impedance analysis was applied to take the appendicular muscle mass into measurement. Appendicular skeletal muscle mass index (ASMI) was calculated. By utilizing HOMA-IR and determining fasting C-peptide levels, insulin resistance (IR) was assessed. Results: According to the median value of ASMI (9.32 kg/m Conclusion: ASMI associates with sarcopenia in middle-aged and older patients with T2DM is tightly linked with IR and pancreatic functionality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.